Scan me!
用微信扫描二维码
分享至好友和朋友圈
    [期刊]
  • 《International Journal of Cancer =: Journal International du Cancer》 2024年154卷12期

摘要 : FOLFOX plus nivolumab represents a standard of care for first-line therapy of advanced gastroesophageal cancer (aGEC) with positive PD-L1 expression. The efficacy of second-line VEGFR-2 inhibition with ramucirumab (RAM) plus chemo... 展开

相关作者
相关关键词